標(biāo)題: Titlebook: Omics for Personalized Medicine; Debmalya Barh,Dipali Dhawan,Nirmal Kumar Ganguly Book 2013 Springer India 2013 Genotype.Nutrition.Pharmac [打印本頁] 作者: 僵局 時(shí)間: 2025-3-21 16:43
書目名稱Omics for Personalized Medicine影響因子(影響力)
書目名稱Omics for Personalized Medicine影響因子(影響力)學(xué)科排名
書目名稱Omics for Personalized Medicine網(wǎng)絡(luò)公開度
書目名稱Omics for Personalized Medicine網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Omics for Personalized Medicine被引頻次
書目名稱Omics for Personalized Medicine被引頻次學(xué)科排名
書目名稱Omics for Personalized Medicine年度引用
書目名稱Omics for Personalized Medicine年度引用學(xué)科排名
書目名稱Omics for Personalized Medicine讀者反饋
書目名稱Omics for Personalized Medicine讀者反饋學(xué)科排名
作者: 方舟 時(shí)間: 2025-3-22 00:17
Personalized Nutrition and Drug–Nutrient Interactionsameters. These factors in fact are essential in dictating the bioavailability, metabolism, and degradation, hence the efficacy of most of the modern drugs. The alternative approach offered by modern nutrigenomics and pharmacogenomics, accounts for such variables in order to intervene in more predictable fashion with better prognosis outcomes.作者: colloquial 時(shí)間: 2025-3-22 00:47
s and its disease-specific applications.Targeted for a broad“Omics for Personalized Medicine” will give to its prospective readers the insight of both the current developments and the future potential of personalized medicine. The book brings into light how the pharmacogenomics and omics technologie作者: 龍蝦 時(shí)間: 2025-3-22 07:07
Pharmacogenomics and Personalized Medicine for Cancerts when prescribed these medicines. In this chapter we provide an overview of the well-studied molecular markers for efficacy and toxicity of cancer therapeutics and also discuss the evolution of the field of companion diagnostics in cancer.作者: 不可接觸 時(shí)間: 2025-3-22 09:16
Book 2013alized medicine. The book brings into light how the pharmacogenomics and omics technologies are bringing a revolution in transforming the medicine and the health care sector for the better. Students of biomedical research and medicine along with medical professionals will benefit tremendously from t作者: Mutter 時(shí)間: 2025-3-22 15:30
Mehmet Gunduz,Muradiye Acar,Kubra Erdogan,Elif Nihat Cetin,Esra Gunduzimited to rocky outcrops or areas of low fuel availability, Ashe juniper has invaded almost 2.7 million hectares (ha) on the Edwards Plateau. Typical characteristics of invasive species often include high photosynthetic rates, distinct seasonal patterns of photosynthesis and growth, flexible resourc作者: cardiac-arrest 時(shí)間: 2025-3-22 19:22
Yousef I. Hassanimited to rocky outcrops or areas of low fuel availability, Ashe juniper has invaded almost 2.7 million hectares (ha) on the Edwards Plateau. Typical characteristics of invasive species often include high photosynthetic rates, distinct seasonal patterns of photosynthesis and growth, flexible resourc作者: APRON 時(shí)間: 2025-3-22 22:26 作者: 沐浴 時(shí)間: 2025-3-23 05:12
Enrique Hernández-Lemus woodland, and forest is a concern not only in the United States but worldwide (Archer et al. 1988; Van Auken 2000; Roques et al. 2001; Silva et al. 2001). Species of woody plants that invade grasslands may include both native plants which previously existed as more minor components of the ecosystem作者: 毗鄰 時(shí)間: 2025-3-23 06:09
Trevor Archer,Anders Fredriksson as we seek to enjoy our environs. In addition, as the first Women, Work and Computerization conference of the new millennium, we hoped to encourage the broad community of scholars that has made past Women, Work and Computerization conferences a success to actively engage in imagining— and working t作者: 機(jī)構(gòu) 時(shí)間: 2025-3-23 13:31
g on the development of personalized medicine in several areas of human health. The topics covered range from metabolic and neurological disorders to non-communicable as well as infectious diseases, and even ex978-81-322-2876-9978-81-322-1184-6作者: NOVA 時(shí)間: 2025-3-23 15:03 作者: Urea508 時(shí)間: 2025-3-23 21:05 作者: 采納 時(shí)間: 2025-3-24 02:05
Melvin George MD., DM.,Sandhiya Selvarajan,Suresh Kumar Srinivasamurthy作者: Harrowing 時(shí)間: 2025-3-24 05:00 作者: Fillet,Filet 時(shí)間: 2025-3-24 06:47 作者: 臭了生氣 時(shí)間: 2025-3-24 13:42
Next-Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Meng technology. NGS is revolutionizing pharmacogenomics and personalized medicine, with several NGS platforms commercially available. Illumina, Roche 454, and Applied Biosystems are the current major vendors. This chapter will characterize the technical assessments of NGS, including comparative analy作者: 得意牛 時(shí)間: 2025-3-24 18:41 作者: parsimony 時(shí)間: 2025-3-24 21:32
Omics Approaches and Applications in Clinical Trialsce of severe drug reactions and better clinical outcome in susceptible patients, is one of the few examples of use of genomics in the area of health care. Pharmacogenomics identifies safety biomarkers and provides an opportunity to rescue a compound that would otherwise fail to be commercialized due作者: MERIT 時(shí)間: 2025-3-25 00:59 作者: 廣口瓶 時(shí)間: 2025-3-25 03:44 作者: 喃喃而言 時(shí)間: 2025-3-25 10:09 作者: 小步舞 時(shí)間: 2025-3-25 13:33 作者: MIRTH 時(shí)間: 2025-3-25 19:00
Pharmacogenomics of Autoimmune Diseasesotrexate. Polymorphisms within the . promoter region have been shown to modify the clinical efficacy and toxicity of anti-TNF therapy in RA patients. SLE patients with polymorphic . gene may require a reduced dose of azathioprine to circumvent the catastrophe of fatal bone marrow suppression. Polymo作者: assent 時(shí)間: 2025-3-25 23:54
Pharmacogenomics and Personalized Medicine in Parkinsonismic makeup. The personalized medication of antiparkinsonian drug therapy; the symptomatic and regional disruptions; genetic, epigenetic, and biomarkers of the disorder; and the pharmacogenomics of neuroleptic drug-induced parkinsonism provide outlets for eventual understanding and management. As a ca作者: 背帶 時(shí)間: 2025-3-26 02:11
Pharmacogenomics and Personalized Medicine in Alzheimer’s Diseaseitter pathways, circuits and regional brain developments, and metabolism that reinforce the growing requirements for personalized medicine. The search for individual-based medication, in addition to genomic assay and biomarker identity, seeks to establish a “reregulation” of destructive β-amyloid pa作者: 駁船 時(shí)間: 2025-3-26 05:05
Pharmacogenomics and Personalized Medicine in Mood Disordersadrenal axis factors, neurotrophic factors, and inflammatory factors affecting neuroimmune function. Nevertheless, procedural considerations of pharmacogenetics presume the parallel investment of policies and regulations to withstand eventual attempts at misuse thereby ensuring patient integrity.作者: 瘋狂 時(shí)間: 2025-3-26 09:05
Book 2013ven discusses the ethical consideration in pharmocogenomics. The second section is focusing on the development of personalized medicine in several areas of human health. The topics covered range from metabolic and neurological disorders to non-communicable as well as infectious diseases, and even ex作者: 滔滔不絕地講 時(shí)間: 2025-3-26 13:13
http://image.papertrans.cn/o/image/700921.jpg作者: interpose 時(shí)間: 2025-3-26 18:05 作者: 凹槽 時(shí)間: 2025-3-26 23:56 作者: braggadocio 時(shí)間: 2025-3-27 03:25 作者: Cryptic 時(shí)間: 2025-3-27 06:21 作者: 討好女人 時(shí)間: 2025-3-27 11:02 作者: Allowance 時(shí)間: 2025-3-27 14:45
Pharmaco-epigenomicson, posttranslational modifications of the histone proteins, and miRNAs are regulating the expression of genes as well as drug-metabolizing genes. Epigenetic regulation is essential for normal developmental and cellular processes. Conversely, abnormal epigenetic regulation is a character of complex 作者: 個(gè)人長篇演說 時(shí)間: 2025-3-27 21:27 作者: 貧窮地活 時(shí)間: 2025-3-28 01:35 作者: TAP 時(shí)間: 2025-3-28 02:25 作者: 不斷的變動(dòng) 時(shí)間: 2025-3-28 09:30
Ethical Considerations in Pharmacogenomicsn a routine basis. However, there are a number of ethical and regulatory challenges such as subject recruitment, privacy, sample collection and storage, and confidentiality, which are of major concern for conducting genomics-based clinical studies. Stratification of clinical study subjects into subg作者: dearth 時(shí)間: 2025-3-28 13:18
Computational Pharmacogenomicsis a recognized fact that the science of pharmacology will also experiment dramatic changes. The search for therapeutic targets has become far too complex to be guided, either by an elevated form of . or by the expert opinion of principal investigators, no matter how rich a wealth of experience and 作者: 最初 時(shí)間: 2025-3-28 15:30
Pharmacogenomics in the Era of Personal Genomics: A Quick Guide to Online Resources and Toolsing on personal genomes. The advent of next-generation sequencing has provided an impetus to personal genomics while at the same time giving an indirect boost to concepts such as pharmacogenomics. Modern-day pharmacogenomics (or PGx) has evolved from the mundane – highlighting variations in common g作者: Aprope 時(shí)間: 2025-3-28 22:24
Pharmacogenomics and Personalized Medicine for Cancerount of data present in literature regarding association studies that have been undertaken around the world with different cancer patient populations. However, some association studies have contradictory results or no association with the studied molecular markers. Many of the genetic tests develope作者: fluffy 時(shí)間: 2025-3-29 01:51 作者: 武器 時(shí)間: 2025-3-29 05:38 作者: 反話 時(shí)間: 2025-3-29 10:06
Pharmacogenomics and Personalized Medicine in Parkinsonismom the emergence of several parallel technologies, such as genomics, transcriptomics, metabolomics, and proteomics which have contributed to and enhanced significantly propensities for generation and testing of pharmacogenomic hypotheses both paralleled and followed by associated developments in the作者: 發(fā)起 時(shí)間: 2025-3-29 11:33
Pharmacogenomics and Personalized Medicine in Alzheimer’s Diseasebehavior abilities, and integrity of brain tissue, present an ever-growing, worldwide dilemma due to aging populations confronted by a related neuropathology. The “amyloid cascade hypothesis,” that pathophysiology is driven by the ever-increasing burden of β-amyloid in the brains of afflicted patien作者: resistant 時(shí)間: 2025-3-29 19:27 作者: 巡回 時(shí)間: 2025-3-29 22:19
Mehmet Gunduz,Muradiye Acar,Kubra Erdogan,Elif Nihat Cetin,Esra Gunduzrom grasslands to woodlands and has subsequently altered the water balance of these plant communities. In many regions of the western United States, juniper trees are the primary woody species encroaching on rangelands (Archer 1994; Van Auken 2000; Ansley et al. 2001). Juniper trees are adapted over作者: 可卡 時(shí)間: 2025-3-30 02:14
Yousef I. Hassanrom grasslands to woodlands and has subsequently altered the water balance of these plant communities. In many regions of the western United States, juniper trees are the primary woody species encroaching on rangelands (Archer 1994; Van Auken 2000; Ansley et al. 2001). Juniper trees are adapted over作者: 北京人起源 時(shí)間: 2025-3-30 07:18
Ye?im Ayd?n Son,?ükrü Tüzmen,Candan H?zel Before European settlement and their introduction of stock-farming practices, these vegetation communities were maintained by periodic fires (Frost 1998) and the grazing/browsing habits of native wildlife (Smeins et al. 1997). These early ranchers did not have experience in semiarid regions, and co作者: Hallmark 時(shí)間: 2025-3-30 10:33 作者: 財(cái)主 時(shí)間: 2025-3-30 14:57
Trevor Archer,Anders Fredriksson sought to cast our net widely. We wanted to encourage presenters to think broadly about women, work and computerization. Towards this end, the programme committee developed a call for papers that, in its final form, requested paper submissions around four related themes. These are (1) Setting the C作者: construct 時(shí)間: 2025-3-30 16:51
9樓作者: fledged 時(shí)間: 2025-3-30 23:40
9樓作者: ATP861 時(shí)間: 2025-3-31 00:57
9樓作者: Infelicity 時(shí)間: 2025-3-31 06:07
9樓作者: LEVER 時(shí)間: 2025-3-31 12:06
10樓作者: gustation 時(shí)間: 2025-3-31 17:01
10樓作者: 表兩個(gè) 時(shí)間: 2025-3-31 17:31
10樓作者: 落葉劑 時(shí)間: 2025-3-31 22:36
10樓
